Richard Glickman

Richard Glickman

Chairman at ENGENE HOLDINGS INC.

Net worth: 649 733 $ as of 2024-04-29

65 year
Health Technology
Finance
Commercial Services

Profile

Richard M.
Glickman
founded Aurinia Pharmaceuticals, Inc. in 1993, where he worked as Chairman & Chief Executive Officer from 2013 to 2019 and Aspreva Pharmaceuticals Corp.
in 2001, where he worked as Chairman & Chief Executive Officer from 2001 to 2006.
Dr. Glickman also founded Probtec Corp., Nventa Biopharmaceuticals Corp., where he worked as Chief Executive Officer, Stressgen Biotechnologies Corp., where he worked as Chief Executive Officer, Ontario Molecular Diagnostics, where he worked as Director, Aurinia Pharmaceuticals, Inc., where he worked as Chief Executive Officer, and Aurinia Pharma Corp., where he worked as Chairman & Chief Executive Officer from 2017 to 2019.
Dr. Glickman also currently works at ESSA Pharma, Inc., as Chairman from 2010, enGene Holdings, Inc., as Chairman from 2024, MedGenesis Therapeutix, Inc., as Director, enGene, Inc., as Director from 2011, Eupraxia Pharmaceuticals, Inc., as Director from 2021, Vida Pharmaceuticals Pvt Ltd., as Director, Eurpraxia Pharmaceuticals, Inc., as Director, and Lumira Capital Investment Management, Inc., as Venture Partner.
Dr. Glickman also formerly worked at Vigil Health Solutions, Inc., as Chairman, LifeSciences British Columbia, as Chairman, BC Biotech, as Chairman, Correvio Pharma Corp., as Lead Independent Director, Canadian Genetic Disease Network, as Director, Vancouver Aquarium, as Director, viDA Therapeutics, Inc., as Director, Innovate BC, as Member, and Kearny Venture Partners, as Venture Partner.
Dr. Glickman received his undergraduate degree from McGill University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-05-27 24,675 ( 0.06% ) 363 216 $ 2024-04-29
2024-04-23 43,240 ( 0.10% ) 264 629 $ 2024-04-29
2024-05-12 7,680 ( 0.02% ) 21 888 $ 2024-04-29

Richard Glickman active positions

CompaniesPositionStart
ESSA PHARMA INC. Chairman 2010-09-30
EUPRAXIA PHARMACEUTICALS INC. Director/Board Member 2021-03-08
ENGENE HOLDINGS INC. Chairman 2024-05-14
Private Equity Investor -
Vida Pharmaceuticals Pvt Ltd. Director/Board Member -
Director/Board Member -
Director/Board Member 2011-09-22
All active positions of Richard Glickman

Former positions of Richard Glickman

CompaniesPositionEnd
AURINIA PHARMACEUTICALS INC. Chief Executive Officer 2019-04-28
Chief Executive Officer 2018-12-31
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░ ░░░░░░░ -
See the detail of Richard Glickman's experience

Training of Richard Glickman

McGill University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Glickman's experience

Connections

100 +

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
EUPRAXIA PHARMACEUTICALS INC.

Health Technology

ESSA PHARMA INC.

Health Technology

AURINIA PHARMACEUTICALS INC.

Health Technology

ENGENE HOLDINGS INC.

Health Technology

Private companies20

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Finance

Stressgen Biotechnologies Corp. /Bioreagents Business/

Health Technology

Commercial Services

Health Technology

Canadian Genetic Disease Network

Finance

Commercial Services

Miscellaneous

Health Technology

Ontario Molecular Diagnostics

Probtec Corp.

Aurinia Pharmaceuticals, Inc. /Old/

Health Technology

Retail Trade

Vida Pharmaceuticals Pvt Ltd.

See company connections
  1. Stock Market
  2. Insiders
  3. Richard Glickman